Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 65 CHF Market Closed
Market Cap: 1B CHF
Have any thoughts about
Cosmo Pharmaceuticals NV?
Write Note

Cosmo Pharmaceuticals NV
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cosmo Pharmaceuticals NV
Operating Expenses Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
G
GHRS
OVB

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Cosmo Pharmaceuticals NV
SIX:COPN
Operating Expenses
-€53.6m
CAGR 3-Years
-20%
CAGR 5-Years
1%
CAGR 10-Years
-6%
Perrigo Company PLC
NYSE:PRGO
Operating Expenses
-$1.3B
CAGR 3-Years
-18%
CAGR 5-Years
0%
CAGR 10-Years
-5%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Operating Expenses
-$2.9B
CAGR 3-Years
-10%
CAGR 5-Years
-17%
CAGR 10-Years
-14%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Operating Expenses
-$188.8m
CAGR 3-Years
-43%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
G
GH Research PLC
NASDAQ:GHRS
Operating Expenses
-$41.2m
CAGR 3-Years
-351%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ovoca Bio PLC
LSE:OVB
Operating Expenses
-€4m
CAGR 3-Years
-5%
CAGR 5-Years
-11%
CAGR 10-Years
7%

See Also

What is Cosmo Pharmaceuticals NV's Operating Expenses?
Operating Expenses
-53.6m EUR

Based on the financial report for Jun 30, 2024, Cosmo Pharmaceuticals NV's Operating Expenses amounts to -53.6m EUR.

What is Cosmo Pharmaceuticals NV's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-6%

Over the last year, the Operating Expenses growth was -53%. The average annual Operating Expenses growth rates for Cosmo Pharmaceuticals NV have been -20% over the past three years , 1% over the past five years , and -6% over the past ten years .

Back to Top